Hepatitis C virus-related liver disease cohort study in Korea
Not Applicable
Recruiting
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0000306
- Lead Sponsor
- Korea Centers for Disease Control and Prevention
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Acute and chronic Hepatitis C Patients
Exclusion Criteria
with out Hepatitis C Patient
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All cause mortality
- Secondary Outcome Measures
Name Time Method History of treatment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are associated with HCV-induced liver fibrosis progression in Korean patients?
How does observational data from KCT0000306 compare to standard-of-care DAAs in HCV-related liver disease outcomes?
Which biomarkers predict treatment response to DAAs in HCV-related liver disease as observed in KCT0000306?
What adverse events are commonly observed in HCV-related liver disease patients enrolled in KCT0000306?
How do emerging HCV therapies in Korea compare with current DAAs based on KCT0000306 cohort findings?